Healius Ltd - Asset Resilience Ratio

Latest as of December 2015: 0.06%

Healius Ltd (HLS) has an Asset Resilience Ratio of 0.06% as of December 2015. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Healius Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$2.43 Million
≈ $1.72 Million USD Cash + Short-term Investments

Total Assets

AU$3.91 Billion
≈ $2.77 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2002–2017)

This chart shows how Healius Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see HLS total asset value.

Liquid Assets Composition Over Time

This chart breaks down Healius Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Healius Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$0.00 0%
Short-term Investments AU$2.43 Million 0.06%
Total Liquid Assets AU$2.43 Million 0.06%

Asset Resilience Insights

  • Limited Liquidity: Healius Ltd maintains only 0.06% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Healius Ltd Industry Peers by Asset Resilience Ratio

Compare Healius Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Green Cross Lab Cell Corporation
KQ:144510
Diagnostics & Research 0.18%
Monash Ivf Group Ltd
AU:MVF
Diagnostics & Research 1.60%
Scope Fluidics SA
WAR:SCP
Diagnostics & Research 16.51%
Eurofins-Cerep SA
PA:ALECR
Diagnostics & Research 13.42%
Check-Cap Ltd
F:7CC
Diagnostics & Research 2.90%
Sonic Healthcare Ltd
AU:SHL
Diagnostics & Research 0.13%
Integral Diagnostics Ltd
AU:IDX
Diagnostics & Research 0.03%
Australian Clinical Labs Ltd
AU:ACL
Diagnostics & Research 4.11%

Annual Asset Resilience Ratio for Healius Ltd (2002–2017)

The table below shows the annual Asset Resilience Ratio data for Healius Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2017-06-30 0.00% AU$0.00
≈ $0.00
AU$3.11 Billion
≈ $2.20 Billion
--
2016-06-30 0.00% AU$0.00
≈ $0.00
AU$3.62 Billion
≈ $2.56 Billion
--
2015-06-30 0.08% AU$3.20 Million
≈ $2.26 Million
AU$3.92 Billion
≈ $2.77 Billion
-0.04pp
2012-06-30 0.12% AU$4.57 Million
≈ $3.24 Million
AU$3.86 Billion
≈ $2.73 Billion
+0.10pp
2011-06-30 0.02% AU$798.00K
≈ $564.64K
AU$3.83 Billion
≈ $2.71 Billion
-0.02pp
2010-06-30 0.04% AU$1.50 Million
≈ $1.06 Million
AU$3.70 Billion
≈ $2.62 Billion
-0.14pp
2009-06-30 0.18% AU$6.93 Million
≈ $4.91 Million
AU$3.78 Billion
≈ $2.67 Billion
+0.18pp
2008-06-30 0.00% AU$115.00K
≈ $81.37K
AU$4.80 Billion
≈ $3.40 Billion
-0.02pp
2007-06-30 0.02% AU$135.00K
≈ $95.52K
AU$606.50 Million
≈ $429.14 Million
+0.02pp
2002-06-30 0.00% AU$-6.00K
≈ $-4.25K
AU$283.35 Million
≈ $200.49 Million
--
pp = percentage points

About Healius Ltd

AU:HLS Australia Diagnostics & Research
Market Cap
$233.78 Million
AU$330.40 Million AUD
Market Cap Rank
#16012 Global
#435 in Australia
Share Price
AU$0.46
Change (1 day)
+7.06%
52-Week Range
AU$0.32 - AU$1.04
All Time High
AU$4.91
About

Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patie… Read more